TASLY - Trademark Details
Status: 700 - Registered
Serial Number
79214474
Registration Number
5477867
Word Mark
TASLY
Status
700 - Registered
Status Date
2018-05-29
Filing Date
2016-11-10
Registration Number
5477867
Registration Date
2018-05-29
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260503, 260505, 260521, 260528 - Incomplete triangles (must have two angles). Triangles made of broken or dotted lines. Triangles that are completely or partially shaded. Miscellaneous designs with overall triangular shape.
Published for Opposition Date
2018-03-13
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
STRUCK, ROBERT J
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of an outline of a shaded triangle with two cut-outs in the shape of horizontal bars crossing through the top half; a smaller shaded triangle appears inside. To the right of the triangles appears the literal element "TASLY".
Goods and Services
Medicine for human purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Chemico-pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Raw material medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Biomedicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; pharmaceutical herbs for medical purposes; Prepared Chinese medicine for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Capsules for medicines, namely, capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Dietetic food and beverages adapted for medical use; bath preparations, medicated; Medical analgesic preparations; preparations for the treatment of burns; Syrups for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; vitamin preparations; sunburn preparations for pharmaceutical purposes; vaccines; detergents for medical purposes; disinfectants for hygiene purposes; digestives for pharmaceutical purposes; mineral water for medical purposes; Mineral salts for medical purposes; purgatives; meal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifuges; medicinal tea; pharmaceutical preparations for the treatment of cranial or facial nerve disorders; anthelmintics; Pharmaceutical Gelatin, namely, gelatin capsules sold empty for pharmaceuticals ; germicides; greases for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal oils; medicinal herbs; Lotions for pharmaceutical purposes, namely, anti-bacteria hand washing solution, oral washings, gynecological washings, anorectal washings; Ointments for pharmaceutical purposes, namely, sunburn ointments, anti-inflammatory ointments, hemorrhoidal ointments, frostbite salve for pharmaceutical purposes, eye ointments; Pectin for pharmaceutical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; herbs teas for medicinal purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; first-aid boxes, filled; medicinal roots; medicinal herbal preparations, namely, tonics medicine; sedatives; soporifics; sugar for medical purposes; Biological preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medical preparations for slimming purposes; by-products of the processing of cereals for dietetic or medical purposes; medicines for dental purposes; Diagnostic preparations for medical purposes for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; medicinal drinks; ferments for pharmaceutical purposes; chemical reagents for medical or veterinary purposes; Dietary fiber to aid digestion; enzyme preparations for medical purposes; amino acids for pharmaceutical purposes; mouthwashes for medical purposes; appetite suppressants for medical purposes; adjuvants for medical purposes; Weight-reducing aid, namely, weight management supplements; Medicine for the treatment of sunburns; Food supplements, namely, antioxidants used for medicinal purposes; acne treatment preparation; Medicinal herbal preparations, namely, lysine electuary; oral rehydration salts; Medicinal liquor for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Medicinal herbal preparations, namely, ginseng electuary; Ginseng for medicinal use; Medicinal herbal preparations, namely, medlar; Dietetic beverages adapted for medicinal purposes, namely, weight-reducing tea; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, fruits; food for babies; milk powder for infants; air purifying preparations; Medicated animal washes; Veterinary preparations for the secondary prevention of coronary heart disease (CHD) and the treatment of acute maintain sickness (AMS) , diabetic retinopathy, asthma, cancer, cardiovascular and cerebrovascular disease, coronary artery disease, angina pectoris, myocardial infarction, cough, depression, diabetes and its complications, enteritis, febris, headache, heart disease, hepatitis, hepatopathy, high blood pressure, hypertriglyceridemia, hypercholesteremia, combined hyperlipidemia, insomnia, fatty liver disease, respiratory tract infection, psychosis, rhinitis; Medicated animal feed; biocides; vermin destroying preparations; sanitary towels; wadding for medical purposes; medical dressings; rubber for dental purposes; teeth filling material; diaper for pets
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-08-21
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited Company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Michael D. Schumann
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1360639
International Registration Date
2016-11-10
International Publication Date
2017-08-17
International Renewal Date
2026-11-10
Auto Protection Date
2019-02-17
International Status
001 - Request for extension of protection established
International Status Date
2017-08-17
Priority Claimed In
True
Priority Claimed Date
2016-05-23
First Refusal In
True
Trademark Events
Event Date | Event Description |
2017-08-17 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2017-08-21 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2017-08-21 | ASSIGNED TO EXAMINER |
2017-08-25 | APPLICATION FILING RECEIPT MAILED |
2017-08-29 | NON-FINAL ACTION WRITTEN |
2017-08-30 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2017-09-01 | REFUSAL PROCESSED BY MPU |
2017-09-01 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2017-09-22 | REFUSAL PROCESSED BY IB |
2017-11-20 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2017-11-20 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-11-21 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-12-07 | ASSIGNED TO EXAMINER |
2017-12-21 | NON-FINAL ACTION WRITTEN |
2017-12-21 | NON-FINAL ACTION E-MAILED |
2017-12-21 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-01-12 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-01-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-01-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-02-01 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-02-10 | REFUSAL PROCESSED BY IB |
2018-02-21 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-03-13 | PUBLISHED FOR OPPOSITION |
2018-03-13 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-05-29 | REGISTERED-PRINCIPAL REGISTER |
2018-08-29 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
2018-09-11 | FINAL DISPOSITION PROCESSED |
2018-09-11 | FINAL DISPOSITION NOTICE SENT TO IB |
2018-09-29 | FINAL DECISION TRANSACTION PROCESSED BY IB |